Oneness Biotech Statistics

Total Valuation

Oneness Biotech has a market cap or net worth of EUR 929.97 million. The enterprise value is 760.12 million.

Market Cap	929.97M
Enterprise Value	760.12M

Important Dates

The last earnings date was Friday, March 7, 2025.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.97%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	308.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-22.14
EV / Sales	231.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-65.26

Financial Position

The company has a current ratio of 39.87, with a Debt / Equity ratio of 0.03.

Current Ratio	39.87
Quick Ratio	38.90
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-1.03
Interest Coverage	-113.02

Financial Efficiency

Return on equity (ROE) is -8.45% and return on invested capital (ROIC) is -4.83%.

Return on Equity (ROE)	-8.45%
Return on Assets (ROA)	-4.68%
Return on Invested Capital (ROIC)	-4.83%
Return on Capital Employed (ROCE)	-8.06%
Revenue Per Employee	80,810
Profits Per Employee	-798,427
Employee Count	43
Asset Turnover	0.01
Inventory Turnover	0.46

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.76% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-61.76%
50-Day Moving Average	11.71
200-Day Moving Average	18.69
Relative Strength Index (RSI)	40.37
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Oneness Biotech had revenue of EUR 3.47 million and -34.33 million in losses. Loss per share was -0.07.

Revenue	3.47M
Gross Profit	1.86M
Operating Income	-32.00M
Pretax Income	-33.88M
Net Income	-34.33M
EBITDA	-20.07M
EBIT	-32.00M
Loss Per Share	-0.07

Full Income Statement

Balance Sheet

The company has 206.82 million in cash and 11.97 million in debt, giving a net cash position of 194.85 million.

Cash & Cash Equivalents	206.82M
Total Debt	11.97M
Net Cash	194.85M
Net Cash Per Share	n/a
Equity (Book Value)	377.16M
Book Value Per Share	0.76
Working Capital	209.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.18 million and capital expenditures -1.46 million, giving a free cash flow of -11.65 million.

Operating Cash Flow	-10.18M
Capital Expenditures	-1.46M
Free Cash Flow	-11.65M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	53.45%
Operating Margin	-920.96%
Pretax Margin	-974.96%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Oneness Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.97%
Shareholder Yield	-0.97%
Earnings Yield	-3.69%
FCF Yield	-1.25%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Oneness Biotech has an Altman Z-Score of 48.44.

Altman Z-Score	48.44
Piotroski F-Score	n/a